DraftKings (DKNG) is down 3.1% today. Here is some analysis on what might have caused this price movement.
Analysis: The pullback appears tied to a mix of fresh financing news and lingering concerns about profitability, taxes, and competition. Investors may be reacting cautiously after DraftKings closed a larger term loan and revolver while an analyst downgrade earlier this week highlighted customer acquisition costs, state tax risk, and pressure from prediction markets.
Details:
Sources:
DraftKings Investor Relations, SEC, 24/7 Wall St.
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$DKNG Insider Trading Activity
$DKNG insiders have traded $DKNG stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $DKNG stock by insiders over the last 6 months:
- PAUL LIBERMAN (See Remarks) has made 0 purchases and 2 sales selling 484,417 shares for an estimated $12,187,931.
- R STANTON DODGE (Chief Legal Officer) has made 0 purchases and 2 sales selling 62,500 shares for an estimated $1,855,202.
- WOODROW LEVIN sold 34,234 shares for an estimated $880,156
- JOCELYN MOORE has made 0 purchases and 2 sales selling 12,909 shares for an estimated $313,793.
- ERIK BRADBURY (Chief Accounting Officer) has made 0 purchases and 3 sales selling 3,745 shares for an estimated $92,634.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$DKNG Hedge Fund Activity
We have seen 294 institutional investors add shares of $DKNG stock to their portfolio, and 532 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CIBC BANCORP USA INC. added 25,080,126 shares (+205.0%) to their portfolio in Q2 2026, for an estimated $633,523,982
- VIKING GLOBAL INVESTORS LP removed 19,119,912 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $413,372,497
- POINTSTATE CAPITAL LP added 8,986,638 shares (+inf%) to their portfolio in Q2 2026, for an estimated $227,002,475
- EMINENCE CAPITAL, LP removed 8,426,755 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $182,186,443
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 7,423,200 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $187,510,032
- AQR CAPITAL MANAGEMENT LLC added 6,815,596 shares (+29.8%) to their portfolio in Q2 2026, for an estimated $172,161,954
- CONTOUR ASSET MANAGEMENT LLC added 4,620,776 shares (+inf%) to their portfolio in Q2 2026, for an estimated $116,720,801
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$DKNG Analyst Ratings
Wall Street analysts have issued reports on $DKNG in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 05/08/2026
To track analyst ratings and price targets for $DKNG, check out Quiver Quantitative's $DKNG forecast page.
$DKNG Price Targets
Multiple analysts have issued price targets for $DKNG recently. We have seen 20 analysts offer price targets for $DKNG in the last 6 months, with a median target of $33.0.
Here are some recent targets:
- Carlo Santarelli from Deutsche Bank set a target price of $28.0 on 07/09/2026
- Joseph Stauff from Susquehanna set a target price of $31.0 on 07/01/2026
- Jordan Bender from Citizens set a target price of $36.0 on 06/25/2026
- Curry Baker from Guggenheim set a target price of $35.0 on 06/24/2026
- Lance Vitanza from TD Cowen set a target price of $30.0 on 06/08/2026
- Robin Farley from UBS set a target price of $49.0 on 06/05/2026
- Nick McKay from Freedom Capital Markets set a target price of $30.0 on 05/21/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.